Literature DB >> 24516056

RASSF7 and RASSF8 proteins are predictive factors for development and metastasis in malignant thyroid neoplasms.

Xi Li, Ge Zhao, Yinghou Wang, Jian Zhang, Zhiquan Duan, Shijie Xin1.   

Abstract

OBJECTIVES: To study the expression status of Ras-association domain family 7 (RASSF7) and Ras-association domain family 8 (RASSF8) in nodular thyroid goiter (NTG), medullary thyroid carcinoma (MTC), and papillary thyroid carcinoma (PTC) and establish whether a correlation exists between the presence of RASSF7 and RASSF8 proteins and clinicopathological parameters of the disease.
MATERIALS AND METHODS: RASSF7 and RASSF8 protein expression was examined immunohistochemically on paraffin-embedded thyroid tissues from 112 cases with PTC, 20 cases with MTC, and 38 cases with NTG.
RESULTS: The immunohistochemical expression of RASSF7 and RASSF8 was higher in PTC and MTC than in NTG (P < 0.001). In thyroid carcinomas, RASSF7 and RASSF8 expression was significantly correlated with a more advanced TNM stage (P = 0.035, P = 0.037), age, sex, lymph node metastasis (P = 0.006, P = 0.002), and tumor size (P = 0.012, P = 0.015).
CONCLUSIONS: RASSF7 and RASSF8 expression was increased in PTC and MTC compared to NTG, and this may be linked to the development and progression of thyroid carcinoma. In addition, these proteins were correlated with more advanced tumor stages, tumor size, and metastasis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24516056     DOI: 10.4103/0973-1482.122519

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  1 in total

1.  The Construction and Analysis of ceRNA Network and Patterns of Immune Infiltration in Mesothelioma With Bone Metastasis.

Authors:  Runzhi Huang; Jiawen Wu; Zixuan Zheng; Guanghua Wang; Dianwen Song; Penghui Yan; Huabin Yin; Peng Hu; Xiaolong Zhu; Haiyun Wang; Qi Lv; Tong Meng; Zongqiang Huang; Jie Zhang
Journal:  Front Bioeng Biotechnol       Date:  2019-10-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.